Clinical Trial Update: To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating SR419 for efficacy and safety in postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• SR419

Snippet

Sponsor: Shanghai SIMR Biotechnology Co., Ltd. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED